The number of drugs prescribed for attention deficit/hyperactivity disorder (ADHD) in England continues to rise steadily, latest NHS figures show.1 Quarterly data from April to June this year showed ...

A study of 150,000 people with ADHD in Sweden confirms that drugs taken to manage the condition have wider benefits beyond improving immediate symptoms ...

A large-scale study of nearly 150,000 individuals has found that starting drug treatment for attention deficit hyperactivity ...

There is no link between prescription opioid use in pregnancy and the risk for autism spectrum disorder or ADHD in offspring, ...

NHS figures show an ongoing rise in drugs prescribed for ADHD at a cost to the health service of £44m between April and June ...

Preschoolers with ADHD are often given medication right after diagnosis, against medical guidelines that recommend starting with behavioral therapy. Limited access to therapy and physician pressures ...

KANSAS CITY, Kan., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...

Strategic Commercial Supply Agreement Positions Lead Asset CTx-1301 for Launch Pending FDA ApprovalKANSAS CITY, Kan., Sept.

Young children with attention deficit/hyperactivity disorder often receive medication just after being diagnosed, which contravenes treatment ...

A new study found that young children with ADHD often receive medication immediately after diagnosis without undergoing six months of behavioral therapy. | Drug Discovery And Development ...

CNS stimulants and ADHD drugs cost £44 million between April 2025 and June 2025 in EnglandPrescriptions for central nervous system (CNS) stimulants and drugs for Attention Deficit Hyperactivity ...